Literature DB >> 20056242

Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.

Anne J Blaschke1, Laurie S Pulver, E Kent Korgenski, Lucy A Savitz, Judy A Daly, Carrie L Byington.   

Abstract

Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20056242      PMCID： PMC3153078          DOI： 10.1016/j.jpeds.2009.10.048

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  14 in total

1.  Group B streptococci: the new challenge in neonatal infections.

Authors:  G H McCracken
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

2.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

Review 3.  Penicillin allergy.

Authors:  J E Erffmeyer
Journal:  Clin Rev Allergy       Date:  1986-05

4.  Early-onset group B streptococcal disease in the era of maternal screening.

Authors:  Karen M Puopolo; Lawrence C Madoff; Eric C Eichenwald
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

5.  Laboratory practices for prenatal group B streptococcal screening--seven states, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-06-18       Impact factor: 17.586

6.  Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy.

Authors:  Kristen A Matteson; Stacey P Lievense; Bethany Catanzaro; Maureen G Phipps
Journal:  Obstet Gynecol       Date:  2008-02       Impact factor: 7.661

7.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system.

Authors:  K M Zangwill; A Schuchat; J D Wenger
Journal:  MMWR CDC Surveill Summ       Date:  1992-11-20

8.  Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin.

Authors:  M D Pearlman; C L Pierson; R G Faix
Journal:  Obstet Gynecol       Date:  1998-08       Impact factor: 7.661

9.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

10.  Antibiotic resistance patterns in invasive group B streptococcal isolates.

Authors:  Mei L Castor; Cynthia G Whitney; Kathryn Como-Sabetti; Richard R Facklam; Patricia Ferrieri; Joanne M Bartkus; Billie A Juni; Paul R Cieslak; Monica M Farley; Nellie B Dumas; Stephanie J Schrag; Ruth Lynfield
Journal:  Infect Dis Obstet Gynecol       Date:  2009-02-05
View more
  4 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Penicillin susceptibility and macrolide-lincosamide-streptogramin B resistance in group B Streptococcus isolates from a Canadian hospital.

Authors:  Kevin Sherman; Sue Whitehead; Edith Blondel-Hill; Ken Wagner; Naowarat Cheeptham
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges.

Authors:  You-Chan Song; Zachary J Nelson; Michael A Wankum; Krista D Gens
Journal:  Pharmacy (Basel)       Date:  2021-07-20

4.  Evaluation of the Results of Group B Streptococcus Screening by MALDI-TOF MS among Pregnant Women in a Hungarian Hospital.

Authors:  Marianna Ábrók; Petra Tigyi; Markus Kostrzewa; Katalin Burián; Judit Deák
Journal:  Pathogens       Date:  2019-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.